These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 8920176)

  • 1. Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.
    Barradell LB; Brogden RN
    Drugs Aging; 1996 Apr; 8(4):299-322. PubMed ID: 8920176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naftidrofuryl: a review of its use in the treatment of intermittent claudication.
    Goldsmith DR; Wellington K
    Drugs Aging; 2005; 22(11):967-77. PubMed ID: 16323973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Naftidrofuryl in arterial obstructive disease: A systematic revue of the literature].
    Bourrion B; Hazard A; Baltazard H; Sebbag P; Fournier L; François M
    Rev Med Interne; 2020 Feb; 41(2):89-97. PubMed ID: 31669163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
    Ranft J; Heidrich H; Lammersen T
    J Mal Vasc; 1987; 12(1):78-81. PubMed ID: 3559415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naftidrofuryl for intermittent claudication.
    de Backer TL; Vander Stichele R; Lehert P; Van Bortel L
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD001368. PubMed ID: 23235580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous naftidrofuryl for critical limb ischaemia.
    Smith FB; Bradbury AW; Fowkes FG
    Cochrane Database Syst Rev; 2000; (2):CD002070. PubMed ID: 10796677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudication.
    Hong H; Mackey WC
    Clin Ther; 2014 Aug; 36(8):1290-301. PubMed ID: 25012728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
    Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
    Br J Surg; 2012 Dec; 99(12):1630-8. PubMed ID: 23034699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF; Davie AM; Clegg JP
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
    Trübestein G; Böhme H; Heidrich H; Heinrich F; Hirche H; Maass U; Mörl H; Rudofsky G
    Angiology; 1984 Nov; 35(11):701-8. PubMed ID: 6388425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the efficacy and tolerance of naftidrofuryl in patients presenting with exertional angina. Multicenter double-blind versus placebo study].
    Hirsch JL; Bensoussan JJ; Mosnier M; Lehert P
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):137-45. PubMed ID: 12555338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naftidrofuryl for intermittent claudication.
    De Backer TL; Vander Stichele R; Lehert P; Van Bortel L
    Cochrane Database Syst Rev; 2008 Apr; (2):CD001368. PubMed ID: 18425872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of naftidrofuryl in patients with intermittent claudication.
    Karnik R; Valentin A; Stöllberger C; Slany J
    Angiology; 1988 Mar; 39(3 Pt 1):234-40. PubMed ID: 3281516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of naftidrofuryl on intermittent claudication: a meta-analysis.
    Lehert P; Riphagen FE; Gamand S
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S81-6. PubMed ID: 1369727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naftidrofuryl in chronic arterial disease. Results of a six month controlled multicenter study using Naftidrofuryl tablets 200 mg.
    Adhoute G; Bacourt F; Barral M; Cardon JM; Chevalier JM; Cuny A; Gillet M; Juhan C; Leguay G; Marion J
    Angiology; 1986 Mar; 37(3 Pt 1):160-7. PubMed ID: 3518547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.
    De Backer T; Vander Stichele R; Lehert P; Van Bortel L
    BMJ; 2009 Mar; 338():b603. PubMed ID: 19276131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
    Meng Y; Squires H; Stevens JW; Simpson E; Harnan S; Thomas S; Michaels J; Stansby G; O'Donnell ME
    Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous naftidrofuryl for critical limb ischaemia.
    Smith FB; Bradbury A; Fowkes G
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD002070. PubMed ID: 22786478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.
    Spitzer S; Bach R; Schieffer H
    Int Angiol; 1992; 11(3):204-10. PubMed ID: 1460355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.